NCT04566393 2026-01-28Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesxCuresAvailable
NCT04681248 2025-08-03Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsLeap Therapeutics, Inc.No longer available